As I said, anything -- could go for something as repaying for the defraying of cost to move diagnostic and screening equipment or public health infrastructure, the purchase of and development of more antiviral medication, or as we get into the development of a seed stock for a vaccine.

WHITEHOUSE: Press Briefing

It is a fast way to go public, and much less expensive than actually doing the footwork and absorbing the cost of doing it the old fashioned way.

FORBES: FBI Ramping Up Interest in Fraud Related To Chinese Reverse Mergers